Espee Formulation Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 18-06-2024
- Paid Up Capital ₹ 6.00 M
as on 18-06-2024
- Company Age 36 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.28 Cr
as on 18-06-2024
- Revenue -4.25%
(FY 2023)
- Profit 43.26%
(FY 2023)
- Ebitda 88.33%
(FY 2023)
- Net Worth -34.12%
(FY 2023)
- Total Assets -4.99%
(FY 2023)
About Espee Formulation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹2.28 Cr.
Vijay Badani, Virendra Kothari, and Jayesh Desai serve as directors at the Company.
- CIN/LLPIN
U24231GJ1988PTC011043
- Company No.
011043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Espee Formulation Private Limited offer?
Espee Formulation Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Dicyclomine Hydrochloride Medicine.
Who are the key members and board of directors at Espee Formulation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Badani  | Whole-Time Director | 28-Jul-1988 | Current |
| Virendra Kothari | Whole-Time Director | 28-Jul-1988 | Current |
| Jayesh Desai | Director | 21-Dec-2016 | Current |
Financial Performance of Espee Formulation.
Espee Formulation Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.25% decrease. The company also saw a substantial improvement in profitability, with a 43.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Espee Formulation?
In 2022, Espee Formulation had a promoter holding of 33.08% and a public holding of 66.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Nov 2021 | ₹2.00 M | Open |
Others Creation Date: 08 Jun 2020 | ₹4.00 M | Open |
Others Creation Date: 27 Dec 2019 | ₹4.44 M | Open |
How Many Employees Work at Espee Formulation?
Espee Formulation has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Espee Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Espee Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
